<i>Staphylococcus aureus</i> Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies.

Front Immunol · 2021 · PMC8294057 · PMID 34305945

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

aureus VAP, however the magnitude of efficacy at 31.9% was not sufficient to meet the efficacy endpoint of the study and furthermore did not reach statistical significance ( 189 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.